Production (Stage)
Labcorp Holdings Inc.
LH
$242.53
$0.640.27%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.18B | 13.01B | 12.71B | 12.49B | 12.30B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.18B | 13.01B | 12.71B | 12.49B | 12.30B |
| Cost of Revenue | 9.50B | 9.38B | 9.16B | 8.99B | 8.89B |
| Gross Profit | 3.68B | 3.62B | 3.55B | 3.50B | 3.41B |
| SG&A Expenses | 2.27B | 2.23B | 2.18B | 2.14B | 2.08B |
| Depreciation & Amortization | 265.90M | 256.40M | 245.20M | 237.20M | 226.50M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.04B | 11.87B | 11.59B | 11.36B | 11.20B |
| Operating Income | 1.14B | 1.14B | 1.13B | 1.12B | 1.10B |
| Income Before Tax | 937.30M | 959.50M | 628.60M | 656.70M | 594.00M |
| Income Tax Expenses | 205.50M | 212.40M | 191.90M | 206.00M | 193.70M |
| Earnings from Continuing Operations | 731.80 | 747.10 | 436.70 | 450.70 | 400.30 |
| Earnings from Discontinued Operations | -- | -- | 0.00 | 0.00 | 33.90M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.00M | -1.10M | -1.20M | -1.20M | -1.10M |
| Net Income | 730.80M | 746.00M | 435.50M | 449.50M | 433.10M |
| EBIT | 1.14B | 1.14B | 1.13B | 1.12B | 1.10B |
| EBITDA | 1.72B | 1.70B | 1.68B | 1.66B | 1.62B |
| EPS Basic | 8.72 | 8.88 | 5.20 | 5.30 | 4.99 |
| Normalized Basic EPS | 7.89 | 8.01 | 8.09 | 8.17 | 7.51 |
| EPS Diluted | 8.66 | 8.83 | 5.15 | 5.26 | 4.95 |
| Normalized Diluted EPS | 7.84 | 7.97 | 8.06 | 8.14 | 7.49 |
| Average Basic Shares Outstanding | 335.30M | 335.80M | 337.10M | 339.70M | 344.30M |
| Average Diluted Shares Outstanding | 337.20M | 337.60M | 338.30M | 340.90M | 345.60M |
| Dividend Per Share | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 |
| Payout Ratio | 33.20% | 32.59% | 56.05% | 55.06% | 58.12% |